glp 1 medi cal coverage GLP-1s and The Payer Predicament π¨ BIG NEWS FOR MEDICARE
Description
Journal reference: Chen, Bandy, et al
Tirzepatide (GLP-1 + GIP): This is a newer, dual-action medication and the same active ingredient as Mounjaro and Zepbound
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)
A study published in Advanced Therapeutics explored the use of a dissolvable microneedle patch to deliver semaglutide in rats, showing promising drug absorption and suggesting the need for further research in humans
doi:10.1002/oby.24067 CDC
Discuss Potential Benefits of GLP-1s for Inflammatory Skin Conditions In conclusion, Dr
